Nodular Prurigo Market Report 2026
Download Free Sample Buy Now
Nodular Prurigo Market Global Report 2026 Market Report Infographic Image

Published : April 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Nodular Prurigo Market Report 2026

Global Outlook – By Type (Chronic Nodular Prurigo, Acute Nodular Prurigo, Subacute Nodular Prurigo), By Treatment Type (Topical Treatments, Systemic Treatments, Phototherapy, Immunosuppressants), By Patient Demographics (Adults, Children, Elderly), By End-User (Hospitals, Homecare, Specialty Clinics, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Nodular Prurigo Market Overview

• Nodular Prurigo market size has reached to $1.25 billion in 2025

• Expected to grow to $1.7 billion in 2030 at a compound annual growth rate (CAGR) of 6.3%

• Growth Driver: Increasing Demand For Targeted Therapies Fueling The Growth Of The Market Due To Their Precision And Improved Patient Outcomes

• Market Trend: Emerging Targeted Therapies Reshaping The Treatment Landscape

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Nodular Prurigo Market?

Nodular prurigo, also known as prurigo nodularis, is a chronic skin condition marked by intensely itchy, firm nodules that commonly appear on the arms, legs, and torso. Nodular prurigo is a chronic skin condition of unclear cause involving immune, nerve, and inflammatory factors where persistent itching leads to excessive scratching, worsening the condition and causing scarring, and typically requires long-term dermatological management.

The main types of nodular prurigo are chronic nodular prurigo, acute nodular prurigo, and subacute nodular prurigo. Chronic nodular prurigo refers to a long-lasting form of prurigo characterized by the development of intensely itchy, firm nodules or bumps on the skin. These are used for various treatment types, including topical treatments, systemic treatments, phototherapy, and immunosuppressants. The various patient demographics include adults, children, and the elderly and are used by various end users such as hospitals, homecare, specialty clinics, and others.

Nodular Prurigo Market Global Report 2026 Market Report bar graph

What Is The Nodular Prurigo Market Size and Share 2026?

The nodular prurigo market size has grown strongly in recent years. It will grow from $1.25 billion in 2025 to $1.33 billion in 2026 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to increasing prevalence of chronic dermatological disorders, limited effectiveness of conventional topical therapies, growing awareness of pruritic skin diseases, expansion of dermatology specialty clinics, improved diagnostic recognition of nodular prurigo.

What Is The Nodular Prurigo Market Growth Forecast?

The nodular prurigo market size is expected to see strong growth in the next few years. It will grow to $1.7 billion in 2030 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to rising development of novel biologics and monoclonal antibodies, increasing focus on personalized dermatology treatments, growing investments in inflammatory skin disease research, expansion of advanced immunotherapy pipelines, increasing demand for long-term itch control solutions. Major trends in the forecast period include increasing adoption of targeted immunomodulatory therapies, rising use of biologic treatments for chronic pruritus, growing focus on neuropathic itch management, expansion of long-term disease management protocols, enhanced emphasis on patient-centric dermatology care.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Nodular Prurigo Market Segmentation

1) By Type: Chronic Nodular Prurigo, Acute Nodular Prurigo, Subacute Nodular Prurigo

2) By Treatment Type: Topical Treatments, Systemic Treatments, Phototherapy, Immunosuppressants

3) By Patient Demographics: Adults, Children, Elderly

4) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users

Subsegments:

1) By Chronic Nodular Prurigo: Idiopathic Chronic Nodular Prurigo, Secondary To Dermatologic Conditions, Neuropathic Causes, Systemic Disease-Associated, Psychogenic Prurigo

2) By Acute Nodular Prurigo: Insect Bite-Induced, Allergic Reactions, Drug-Induced Prurigo, Infectious Triggers

3) By Subacute Nodular Prurigo: Healing Phase Of Chronic Prurigo, Post-Inflammatory Prurigo, Transient Dermatoses, Reaction To Environmental Irritants

What Is The Driver Of The Nodular Prurigo Market?

The increasing demand for targeted therapies is expected to propel the growth of the nodular prurigo market going forward. Targeted therapies refer to the medical treatments that specifically target and interfere with molecular pathways involved in the growth and spread of diseases. The rising demand for targeted therapies can be due to their ability to provide more precise treatments with fewer side effects, improving patient outcomes and offering alternatives to traditional, less specific therapies. Nodular prurigo helps drive the development of targeted therapies by presenting a clear unmet medical need involving specific immune pathways such as IL-4, IL-13, and IL-31, which enables the use of biologics that precisely block these inflammatory signals for more effective treatment. For instance, in January 2024, according to the American Society of Gene & Cell Therapy, a US-based organization for gene and cell therapy, in Q4 2023, the number of gene therapies in Phase III increased by 10% from the previous quarter, marking the first rise since Q3 2022. Therefore, the increasing demand for targeted therapies is driving growth in the nodular prurigo industry.

Key Players In The Global Nodular Prurigo Market

Major companies operating in the nodular prurigo market are Merck and Co Inc, Sanofi SA, GlaxoSmithKline plc, Amgen Inc, Regeneron Pharmaceuticals Inc, Astellas Pharma Inc, Sun Pharmaceutical Industries Limited, Galderma SA, Incyte Corporation, Kyowa Kirin Co Ltd, LEO Pharma AS, Maruho Co Ltd, Kiniksa Pharmaceuticals Ltd, Keymed Biosciences Co Ltd, Trevi Therapeutics Inc, Menlo Therapeutics Inc, VYNE Therapeutics Inc, Celldex Therapeutics Inc, AbbVie Inc, Pfizer Inc, Novartis AG, Eli Lilly and Company

Global Nodular Prurigo Market Trends and Insights

Major companies operating in the nodular prurigo market are focusing on developing innovative solutions, such as anti-IL-31 receptor biologic, to meet the rising demand for disease-modifying therapies that reduce intense chronic itch, improve nodule resolution, and lower reliance on long-term topical corticosteroids and broad immunosuppressants. An anti-IL-31 receptor monoclonal antibody is a biologic therapy composed of engineered humanized antibodies that bind the IL-31 receptor A on sensory and immune cells, blocking IL-31 signaling which is implicated in chronic pruritus. For instance, in August 2024, Galderma S.A., a Switzerland-based dermatology pharmaceutical company, launched Nemluvio (nemolizumab), an innovative anti-IL-31 receptor monoclonal antibody for adults living with prurigo nodularis. Nemluvio (nemolizumab) is a humanized monoclonal antibody formulated for subcutaneous injection that binds IL-31 receptor A to interrupt itch signaling and downstream inflammatory pathways; it was developed to reduce intense chronic itch and promote healing of pruritic nodules, and is supplied as an autoinjector for outpatient use. Unique features include its targeted mechanism, systemic activity suitable for widespread disease, and a dosing format intended to improve patient adherence compared with clinic-only infusions.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Nodular Prurigo Market?

In April 2024, Incyte Corporation, a US-based pharmaceutical company, partnered with China Medical System Holdings Limited to advance treatments for various autoimmune and inflammatory dermatologic conditions, including non-segmental vitiligo, hidradenitis suppurativa, prurigo nodularis, asthma, and chronic spontaneous urticaria. China Medical System Holdings Limited is a Hong Kong-based pharmaceutical company that is involved in nodular prurigo treatment.

Regional Outlook

North America was the largest region in the nodular prurigo market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Nodular Prurigo Market?

The nodular prurigo market consists of revenues earned by entities by providing services such as diagnosis and clinical evaluation, prescription of topical treatments, phototherapy, biologic therapies, and supportive care. The market value includes the value of related goods sold by the service provider or included within the service offering. The nodular prurigo market also includes sales of products including oral antidepressants, JAK inhibitors, and topical calcineurin inhibitors. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Nodular Prurigo Market Report 2026?

The nodular prurigo market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the nodular prurigo industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Nodular Prurigo Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $1.33 billion
Revenue Forecast In 2035 $1.7 billion
Growth Rate CAGR of 6.6% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Type, Treatment Type, Patient Demographics, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Merck and Co Inc, Sanofi SA, GlaxoSmithKline plc, Amgen Inc, Regeneron Pharmaceuticals Inc, Astellas Pharma Inc, Sun Pharmaceutical Industries Limited, Galderma SA, Incyte Corporation, Kyowa Kirin Co Ltd, LEO Pharma AS, Maruho Co Ltd, Kiniksa Pharmaceuticals Ltd, Keymed Biosciences Co Ltd, Trevi Therapeutics Inc, Menlo Therapeutics Inc, VYNE Therapeutics Inc, Celldex Therapeutics Inc, AbbVie Inc, Pfizer Inc, Novartis AG, Eli Lilly and Company
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Nodular Prurigo Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Nodular Prurigo Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Nodular Prurigo Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Nodular Prurigo Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Artificial Intelligence & Autonomous Intelligence

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Adoption Of Targeted Immunomodulatory Therapies

4.2.2 Rising Use Of Biologic Treatments For Chronic Pruritus

4.2.3 Growing Focus On Neuropathic Itch Management

4.2.4 Expansion Of Long-Term Disease Management Protocols

4.2.5 Enhanced Emphasis On Patient-Centric Dermatology Care

5. Nodular Prurigo Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Dermatology Clinics

5.3 Homecare Settings

5.4 Research Institutes

5.5 Academic Medical Centers

6. Nodular Prurigo Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Nodular Prurigo Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Nodular Prurigo PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Nodular Prurigo Market Size, Comparisons And Growth Rate Analysis

7.3. Global Nodular Prurigo Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Nodular Prurigo Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Nodular Prurigo Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Nodular Prurigo Market Segmentation

9.1. Global Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Chronic Nodular Prurigo, Acute Nodular Prurigo, Subacute Nodular Prurigo

9.2. Global Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Topical Treatments, Systemic Treatments, Phototherapy, Immunosuppressants

9.3. Global Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Adults, Children, Elderly

9.4. Global Nodular Prurigo Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Homecare, Specialty Clinics, Other End-Users

9.5. Global Nodular Prurigo Market, Sub-Segmentation Of Chronic Nodular Prurigo, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Idiopathic Chronic Nodular Prurigo, Secondary To Dermatologic Conditions, Neuropathic Causes, Systemic Disease-Associated, Psychogenic Prurigo

9.6. Global Nodular Prurigo Market, Sub-Segmentation Of Acute Nodular Prurigo, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Insect Bite-Induced, Allergic Reactions, Drug-Induced Prurigo, Infectious Triggers

9.7. Global Nodular Prurigo Market, Sub-Segmentation Of Subacute Nodular Prurigo, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Healing Phase Of Chronic Prurigo, Post-Inflammatory Prurigo, Transient Dermatoses, Reaction To Environmental Irritants

10. Nodular Prurigo Market Regional And Country Analysis

10.1. Global Nodular Prurigo Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Nodular Prurigo Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Nodular Prurigo Market

11.1. Asia-Pacific Nodular Prurigo Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Nodular Prurigo Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Nodular Prurigo Market

12.1. China Nodular Prurigo Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Nodular Prurigo Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Nodular Prurigo Market

13.1. India Nodular Prurigo Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Nodular Prurigo Market

14.1. Japan Nodular Prurigo Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Nodular Prurigo Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Nodular Prurigo Market

15.1. Australia Nodular Prurigo Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Nodular Prurigo Market

16.1. Indonesia Nodular Prurigo Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Nodular Prurigo Market

17.1. South Korea Nodular Prurigo Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Nodular Prurigo Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Nodular Prurigo Market

18.1. Taiwan Nodular Prurigo Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Nodular Prurigo Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Nodular Prurigo Market

19.1. South East Asia Nodular Prurigo Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Nodular Prurigo Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Nodular Prurigo Market

20.1. Western Europe Nodular Prurigo Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Nodular Prurigo Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Nodular Prurigo Market

21.1. UK Nodular Prurigo Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Nodular Prurigo Market

22.1. Germany Nodular Prurigo Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Nodular Prurigo Market

23.1. France Nodular Prurigo Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Nodular Prurigo Market

24.1. Italy Nodular Prurigo Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Nodular Prurigo Market

25.1. Spain Nodular Prurigo Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Nodular Prurigo Market

26.1. Eastern Europe Nodular Prurigo Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Nodular Prurigo Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Nodular Prurigo Market

27.1. Russia Nodular Prurigo Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Nodular Prurigo Market

28.1. North America Nodular Prurigo Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Nodular Prurigo Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Nodular Prurigo Market

29.1. USA Nodular Prurigo Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Nodular Prurigo Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Nodular Prurigo Market

30.1. Canada Nodular Prurigo Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Nodular Prurigo Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Nodular Prurigo Market

31.1. South America Nodular Prurigo Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Nodular Prurigo Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Nodular Prurigo Market

32.1. Brazil Nodular Prurigo Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Nodular Prurigo Market

33.1. Middle East Nodular Prurigo Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Nodular Prurigo Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Nodular Prurigo Market

34.1. Africa Nodular Prurigo Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Nodular Prurigo Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Nodular Prurigo Market Regulatory and Investment Landscape

36. Nodular Prurigo Market Competitive Landscape And Company Profiles

36.1. Nodular Prurigo Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Nodular Prurigo Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Nodular Prurigo Market Company Profiles

36.3.1. Merck and Co Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis

36.3.3. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Amgen Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Regeneron Pharmaceuticals Inc Overview, Products and Services, Strategy and Financial Analysis

37. Nodular Prurigo Market Other Major And Innovative Companies

Astellas Pharma Inc, Sun Pharmaceutical Industries Limited, Galderma SA, Incyte Corporation, Kyowa Kirin Co Ltd, LEO Pharma AS, Maruho Co Ltd, Kiniksa Pharmaceuticals Ltd, Keymed Biosciences Co Ltd, Trevi Therapeutics Inc, Menlo Therapeutics Inc, VYNE Therapeutics Inc, Celldex Therapeutics Inc, AbbVie Inc, Pfizer Inc

38. Global Nodular Prurigo Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Nodular Prurigo Market

40. Nodular Prurigo Market High Potential Countries, Segments and Strategies

40.1 Nodular Prurigo Market In 2030 - Countries Offering Most New Opportunities

40.2 Nodular Prurigo Market In 2030 - Segments Offering Most New Opportunities

40.3 Nodular Prurigo Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Nodular Prurigo Market, Overview Of Key Products - Product Examples
  • Table 2: Global Nodular Prurigo Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Nodular Prurigo Market, Supply Chain Analysis
  • Table 4: Global Nodular Prurigo Market, Major Raw Material Providers
  • Table 5: Global Nodular Prurigo Market, Major Resource Providers
  • Table 6: Global Nodular Prurigo Market, Major Manufacturers (Suppliers)
  • Table 7: Global Nodular Prurigo Market, Major Distributors And Channel Partners
  • Table 8: Global Nodular Prurigo Market, Key Technologies & Future Trends
  • Table 9: Global Nodular Prurigo Market, Major Trends
  • Table 10: Global Nodular Prurigo Market, Major End Users
  • Table 11: Global Nodular Prurigo Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Nodular Prurigo Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Nodular Prurigo Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Nodular Prurigo Market - TAM, US$ Billion, 2025
  • Table 15: Global Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Nodular Prurigo Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Nodular Prurigo Market, Sub-Segmentation Of Chronic Nodular Prurigo, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Nodular Prurigo Market, Sub-Segmentation Of Acute Nodular Prurigo, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Nodular Prurigo Market, Sub-Segmentation Of Subacute Nodular Prurigo, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Nodular Prurigo Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Nodular Prurigo Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Global Nodular Prurigo Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 97: Global Nodular Prurigo Market - Company Scoring Matrix
  • Table 98: Merck and Co Inc Financial Performance
  • Table 99: Sanofi SA Financial Performance
  • Table 100: GlaxoSmithKline plc Financial Performance
  • Table 101: Amgen Inc Financial Performance
  • Table 102: Regeneron Pharmaceuticals Inc Financial Performance
  • Table 103: Global Nodular Prurigo Market, Competitive Benchmarking (In USD Billions)
  • Table 104: Global Nodular Prurigo Market, Competitive Dashboard
  • Table 105: Global Nodular Prurigo Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 106: Global, Nodular Prurigo Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Table 107: Global, Nodular Prurigo Market Size Gain ($ Billion), Segmentation By Treatment Type, 2025 – 2030
  • Table 108: Global, Nodular Prurigo Market Size Gain ($ Billion), Segmentation By Patient Demographics, 2025 – 2030

List Of Figures

    Figure 1: Global Nodular Prurigo Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Nodular Prurigo Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Nodular Prurigo Market, Supply Chain Analysis
  • Figure 4: Global Nodular Prurigo Market, Major Raw Material Providers
  • Figure 5: Global Nodular Prurigo Market, Major Resource Providers
  • Figure 6: Global Nodular Prurigo Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Nodular Prurigo Market, Major Distributors And Channel Partners
  • Figure 8: Global Nodular Prurigo Market, Key Technologies & Future Trends
  • Figure 9: Global Nodular Prurigo Market, Major Trends
  • Figure 10: Global Nodular Prurigo Market, Major End Users
  • Figure 11: Global Nodular Prurigo Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Nodular Prurigo Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Nodular Prurigo Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Nodular Prurigo Market - TAM, US$ Billion, 2025
  • Figure 15: Global Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Nodular Prurigo Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Nodular Prurigo Market, Sub-Segmentation Of Chronic Nodular Prurigo, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Nodular Prurigo Market, Sub-Segmentation Of Acute Nodular Prurigo, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Nodular Prurigo Market, Sub-Segmentation Of Subacute Nodular Prurigo, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Nodular Prurigo Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Nodular Prurigo Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Nodular Prurigo Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Nodular Prurigo Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Nodular Prurigo Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Global Nodular Prurigo Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 97: Global Nodular Prurigo Market - Company Scoring Matrix
  • Figure 98: Merck and Co Inc Financial Performance
  • Figure 99: Sanofi SA Financial Performance
  • Figure 100: GlaxoSmithKline plc Financial Performance
  • Figure 101: Amgen Inc Financial Performance
  • Figure 102: Regeneron Pharmaceuticals Inc Financial Performance
  • Figure 103: Global Nodular Prurigo Market, Competitive Benchmarking (In USD Billions)
  • Figure 104: Global Nodular Prurigo Market, Competitive Dashboard
  • Figure 105: Global Nodular Prurigo Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 106: Global, Nodular Prurigo Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Figure 107: Global, Nodular Prurigo Market Size Gain ($ Billion), Segmentation By Treatment Type, 2025 – 2030
  • Figure 108: Global, Nodular Prurigo Market Size Gain ($ Billion), Segmentation By Patient Demographics, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

Read More About Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Read More About Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Read More About CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

Read More About Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Read More About Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Pruritus Therapeutic Market Report 2026 - Global Outlook – By Type (Corticosteroids, Antihistamines, Local Anesthetics, Counterirritants, Immunosuppressant, Calcineurin Inhibitors, Others Types), By Disease Type (Atopic ...

Pruritus Therapeutics Market Report 2026 - Global Outlook – By Product (Corticosteroids, Antihistamines, Local Anesthetics, Counterirritants, Immunosuppressants, Calcineurin Inhibitors, Other Products), By Route Of Admin...

Caprolactam Market Report 2026 - Global Outlook – By Raw Material (Phenol, Cyclohexane, Hydroxylamine Sulfate), By Application (Nylon 6 Filaments, Textile Yarn, Nylon 6 Fibers, Engineering Plastics, Other Applications), ...

Neem Extract Market Report 2026 - Global Outlook – By Type (Leaf Extract, Fruit And Seed Extract, Bark Extract), By Formulation (Dry, Liquid), By Application (Food And Beverages, Pharmaceutical, Nutraceutical, Personal C...

Isotretinoin Drugs Market Report 2026 - Global Outlook – By Form (Capsules, Injection), By Indication Type (Severe Acne, Neuroblastoma, Cutaneous T-Cell Lymphoma, Harlequin Ichthyosis, Xeroderma Pigmentosum, Fibrodysplas...

Retinol Market Report 2026 - Global Outlook – By Type (Natural, Synthetic), By Application (Personal Care And Cosmetics, Dietary Supplements, Food And Beverage, Animal Feed, Other Applications), By Distribution Channel (...

Angina Pectoris Drugs Market Report 2026 - Global Outlook – By Drugs (Nitrates, Antiplatelet Agents, Beta-adrenergic Blocking Agents, Calcium Channel Blockers, Anti-ischemic Agents, Statins), By Indication (Stable Angina...

Propanol Market Report 2026 - Global Outlook – By Type (Iso-Propanol, N-propanol), By Grade (Technical Grade, Pharmaceutical Grade, Cosmetic Grade), By End User (Pharmaceuticals, Chemicals, Personal Care, Printing Inks, ...

Frequently Asked Questions

The Nodular Prurigo market was valued at $1.25 billion in 2025, increased to $1.33 billion in 2026, and is projected to reach $1.7 billion by 2030.

The global Nodular Prurigo market is expected to grow at a CAGR of 6.3% from 2026 to 2035 to reach $1.7 billion by 2035.

Some Key Players in the Nodular Prurigo market Include, Merck and Co Inc, Sanofi SA, GlaxoSmithKline plc, Amgen Inc, Regeneron Pharmaceuticals Inc, Astellas Pharma Inc, Sun Pharmaceutical Industries Limited, Galderma SA, Incyte Corporation, Kyowa Kirin Co Ltd, LEO Pharma AS, Maruho Co Ltd, Kiniksa Pharmaceuticals Ltd, Keymed Biosciences Co Ltd, Trevi Therapeutics Inc, Menlo Therapeutics Inc, VYNE Therapeutics Inc, Celldex Therapeutics Inc, AbbVie Inc, Pfizer Inc, Novartis AG, Eli Lilly and Company .

Major trend in this market includes: Emerging Targeted Therapies Reshaping The Treatment Landscape. For further insights on this market. request a sample here

North America was the largest region in the nodular prurigo market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nodular prurigo market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us